Abstract
Chemotherapy with anticancer drugs is known to be beneficial, but like a double-edged sword, it has its own demerits in the form of adverse effects. Cancer chemotherapy-induced thrombocytopenia is troublesome, and platinum-based regimens, namely carboplatin and cisplatin, are known to cause it very commonly. Gemcitabine, in combination with platinum compounds, is known to cause severe thrombocytopenia. Hence, we report a case of thrombocytopenia induced by gemcitabine when used as a single agent in the treatment of ovarian cancer.
| Original language | English |
|---|---|
| Pages (from-to) | 17-18 |
| Number of pages | 2 |
| Journal | Asian Journal of Pharmaceutical and Clinical Research |
| Volume | 10 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 01-01-2017 |
| Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Pharmacology
- Pharmaceutical Science
- Pharmacology (medical)
Fingerprint Dive into the research topics of 'Gemcitabine-induced drop in platelet counts: A case report'. Together they form a unique fingerprint.
Cite this
Balaji, O., Amita, D., Sereen, R. T., & Navin, P. (2017). Gemcitabine-induced drop in platelet counts: A case report. Asian Journal of Pharmaceutical and Clinical Research, 10(5), 17-18. https://doi.org/10.22159/ajpcr.2017.v10i5.17297